Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...

Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s ...

BAYRY beats on Q2 earnings and raises 2025 sales outlook (on a currency-adjusted basis) as pharma growth offsets currency and ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

Bayer has cut more than one in 10 jobs since the launch of a sweeping restructuring programme aimed at streamlining decision-making and reducing layers of management.

The German giant has already trimmed more than 10,000 employees since initiating a massive restructuring initiative in July ...

The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – a fall of ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1100 ET – Bayer is expecting a historically high U.S. corn ...

We affirm our objective to significantly contain the litigation risk by the end of 2026,” CEO Bill Anderson noted said. As part of its ...

Bayer on Wednesday said it would be forced to stop its U.S. production of widely-used farming weedkiller glyphosate unless ...

Miner and trader Glencore said on Wednesday that its long-term strategy could involve the sale of its 16.4 per cent stake in ...